New Jersey S3822 requires Medicaid coverage for remote stress tests for pregnant women.

New Jersey S3822 mandates Medicaid coverage for remote stress tests for pregnant women. These tests, approved by the U.S. Food and Drug Administration, allow for at-home monitoring of fetal heart rate, fetal movement, and uterine contractions. The bill aims to address the challenge many pregnant women face in undergoing prescribed contraction stress tests, which can be crucial for managing high-risk pregnancies and reducing maternal mortality. By enabling remote testing, the legislation seeks to improve access and adherence to necessary prenatal care.

New Jersey S3822 requires Medicaid coverage for remote stress tests for pregnant women.

New Jersey S3822 mandates Medicaid coverage for remote stress tests for pregnant women. These tests, approved by the U.S. Food and Drug Administration, allow for at-home monitoring of fetal heart rate, fetal movement, and uterine contractions. The bill aims to address the challenge many pregnant women face in undergoing prescribed contraction stress tests, which can be crucial for managing high-risk pregnancies and reducing maternal mortality. By enabling remote testing, the legislation seeks to improve access and adherence to necessary prenatal care.